6N6-21276-14845
4 vaccinations
6 coded responses
35 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 946 / CA
- Registered
- 2021-05-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-15
Dose 1 — Moderna
-
2021-05-13
Registered in v-safe
-
2021-05-13
Dose 2 — Moderna
- 2021-05-13
-
2021-05-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2021-05-17
- 2021-05-18
- 2021-05-27
- 2021-06-05
- 2021-06-12
- 2021-06-18
- 2021-06-24
- 2021-08-12
- 2021-11-13
-
2022-03-16
Dose 3 — Moderna
-
2022-03-18
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolFree text: Swollen lymph nodes in my armpitMedDRA releases: 2024-11 · check-in free text available
-
2022-03-19
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessFree text: Swollen lymph nodes in my armpitMedDRA releases: 2024-11 · check-in free text available
-
2022-03-20
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Swelling · NauseaFree text: Swollen lymph nodesMedDRA releases: 2024-11 · check-in free text available
-
2022-03-21
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Redness, SwellingFree text: Swollen lymph nodesMedDRA releases: 2024-11 · check-in free text available
- 2022-04-01
- 2022-04-06
- 2022-04-13
- 2022-04-27
- 2022-06-15
-
2022-09-14
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I had COVID August 5-16MedDRA releases: 2024-11 · check-in free text available
- 2023-03-16
-
2023-04-04
Dose 4 — Moderna
-
2023-04-05
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2023-04-06
- 2023-04-07
- 2023-04-08
- 2023-04-09
- 2023-04-10
- 2023-04-11
- 2023-04-18
-
2023-04-25
Survey response — day 21, dose 4MedDRA: Dizziness, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-05-02
- 2023-05-10
- 2023-05-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-15 | Moderna | |
| 2 | 2021-05-13 | Moderna | |
| 3 | 2022-03-16 | Moderna | No |
| 4 | 2023-04-04 | Moderna | No |
Free text
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen lymph nodes in my armpit
Systemic reaction (other): Swollen lymph nodes in my armpit
Systemic reaction (other): Swollen lymph nodes
Systemic reaction (other): Swollen lymph nodes
Release 12 — 6 months, dose 3
Symptoms: I had COVID August 5-16
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release